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Abstract
Microbial fuel cell (MFC) technology is currently gaining recognition as one of the most promising bioenergy technologies of 
the future. One aspect of this technology that has received little attention is the disinfection of effluents and the fate of patho-
genic organisms that find their way into the waste stream. In this study, three independent trials were carried out to evaluate 
the fate of three bioluminescent pathogenic bacteria (Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa 
and Staphylococcus aureus) introduced into the anodic chamber of a urine-fed cascade of 9 MFCs with matured, electroac-
tive biofilms. These are common examples of enteric human pathogens, which could contaminate urine or waste streams. 
The results showed that the average power generation in the closed circuit cascade reached 754 ± 16 µW, with an average 
pathogen log-fold reduction of 6.24 ± 0.63 compared to 2.01 ± 0.26 for the open circuit cascade for all three pathogens. The 
results suggest that the bio-electrochemical reactions associated with electricity generation were the primary driving force for 
the inactivation of the introduced pathogens. These findings show that pathogenic organisms introduced into waste streams 
could be inactivated by the power-generating process within the MFC cascade system, thereby preventing propagation and 
thus rendering the effluent safer for possible reuse.
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Introduction
The microbial fuel cell (MFC) is an innovative technol-
ogy for the direct conversion of organic matter into elec-
tricity. MFCs exploit the unique ability of certain bacteria 
to donate electrons to an anode electrode, as part of their 
natural metabolism. Electricity is generated as a result of 
organic matter degradation as the anode becomes the termi-
nal electron acceptor [6, 15, 26]. Interest in MFCs has grown 
significantly over the past decade possibly as a result of dem-
onstrating a wide range of applications [32]. Although much 
of the interest in the technology has been fuelled by the quest 
for better wastewater management, due to more stringent 
water discharge limits [11], there are currently many other 
applications where MFCs could be implemented [6, 26]. 
More recently, the use of neat human urine as the sole feed-
stock has been widely reported with promising applications 
in powering portable devices such as mobile phones [12, 
14, 23, 36]. Urine is particularly suited as a feedstock for 
MFC applications because of its abundance, composition of 
suitable nutrients for microbial growth, as well as its high 
conductivity [4, 23, 39, 41]. It has been demonstrated as a 
promising technology for addressing energy and environ-
mental issues particularly in poor and remote areas of the 
world [1, 30].
Most of the current interest in MFCs is understandably 
focused on the optimisation of the overall power output by 
enhancing different aspects of the technology. Some of these 
include coating the carbon anodes with ionic liquid polymer 
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[37], miniaturisation [14], controlling anodic biofilms [22] 
as well as the modification of other parameters involved in 
the MFC technology [3].
Although significant advances have been made in gen-
erally improving the performance of the MFC technology, 
other aspects have remained largely underexploited. One 
area of technological implementation, which has received 
very little attention, is the fate of pathogenic organisms that 
may be introduced into the system with potential public 
health implications resulting from its operation. Wastewater 
and urine treatment using MFCs carry the potential risk of 
faecal contamination and introduction of different associated 
pathogens into the waste stream. Improper waste manage-
ment, resulting in faecal contamination of water and food 
resources, leads to thousands of deaths every year as a result 
of diseases caused by pathogenic organisms such as E. coli 
and Salmonella sp. [24]. This is still commonplace in sub-
Saharan Africa [16], Southeast Asia [18] and South America 
[21], areas which would likely benefit the most from MFCs 
based on the favourable environmental conditions and the 
need for energy and sanitation [1]. It is therefore important 
to examine the fate of pathogenic organisms in waste streams 
during the MFC-led power generation process as well as 
post-MFC treatment, to evaluate the risk of infections. This 
is also of greater importance where the treated effluents are 
to be utilised in further applications such as irrigation.
Previous work has reported on the ability of MFCs or the 
MFC process by-products to suppress the growth of microor-
ganisms. For example, a recent research in our lab conducted 
by Gajda et al. [8] highlighted the bactericidal properties 
of the synthesised catholyte from the cathodic chamber of 
ceramic-based MFCs treating wastewater. In their report, 
catholyte was applied to bioluminescent E. coli and moni-
tored with a bench top luminometer with the results show-
ing significant reduction (> 4 log-fold) in E. coli viability 
over a period of 120 s compared to the open circuit controls 
(< 1 log-fold over the same period). Although this previous 
report highlighted the unique application for the synthesised 
catholyte, it did not provide any information on antisepsis 
occurring in the anodic chamber.
Some unique characteristics of the MFC anodic chamber 
provide an indication for its ability to suppress the growth 
of exogenous microorganisms that might be introduced to it. 
As such, there is a possibility of exploiting these qualities to 
achieve disinfection of any contaminated influent—whether 
urine or wastewater. Some of these characteristics within the 
anodic chamber are hypothesised to be: (1) competition for 
energy source; (2) high pH (> 9.5) which can be obtained in 
urine-powered MFCs and the electroactive nature of power-
generating MFCs.
Our recent study reported that the anodic chamber of 
ceramic-based, 3D-printed urine-powered MFCs could bring 
about considerable pathogen inactivation as a result of the 
power generation process [12]. In this previous research, 
real pathogenic Salmonella enterica serovar Enteritidis 
was introduced into the anodic chamber of the MFCs and 
monitored in real time in a cascade system. The results 
highlighted differences in disinfection efficacy between 
the power-generating cascade (closed circuit) and the open 
circuit cascade. The closed circuit cascade effected greater 
than four log-fold reduction in both viable counts and bio-
luminescence (of a bioluminescent genetically modified 
(GM) variant of the pathogen). The study indicated that 
pH, oxidation–reduction potential (ORP) and the electron 
flow achieved in the anodic chamber of closed circuit MFCs 
could suppress the growth and deactivate S. enteritidis, a 
diarrhoea-causing bacterium [12].
The current study reported herewith aims at investigat-
ing the fate of three different model pathogens introduced 
into two different microbial fuel cell cascade systems, with 
a well-developed electroactive biofilm community. These 
pathogens are often associated with faecal contamination 
and improper waste management, resulting in disease out-
breaks [16, 18] and it is therefore important to assess their 
fate within the anodic chamber of urine-fed MFCs in a con-
tinuous flow system in situ. The choice of organism was 
mainly informed by the wide range of applications for MCF 
technology (such as in the treatment of domestic wastewa-
ter, faecal sludge including urine and hospital wastewater, 
amongst others). Although the tested organisms might not 
be directly obtained from neat urine, the possibility of fae-
cal cross-contamination is high. Furthermore, Pseudomonas 
aeruginosa found in soil and water can cause urinary tract 
infections; as such, it is highly likely to be present in the 
urine of infected individuals. The MFC unit size investiga-
tion allows for a better evaluation of the inactivation effi-
cacy and therefore a better design for the implementation. 
This provides a wider investigation into both Gram-positive 
(Staphylococcus aureus) and Gram-negative (Salmonella 
enteritidis serovar Typhimurium and P. aeruginosa) species.
Materials and methods
MFC reactor construction and operation
Three different trials were conducted, which employed two 
different sizes of MFCs; in the first trial (Trial 1), smaller 
MFCs were used with only S. typhimurium tested as the 
target pathogen, whereas in the second trial (Trial 2), larger 
MFCs were tested with all three pathogens as the target 
species; to separate the pathogenic species, the experiments 
with S. aureus were called “Trial 3”, but were conducted 
with the same larger MFCs of Trial 2.
The smaller MFCs in Trial 1 were built from earthenware 
ceramic membrane and supplied with carbon veil anode and 
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carbon-painted cathode. Their design has been described in 
detail previously [27]. The internal volume of each empty 
MFC was 11.4 mL. The MFC setup consisted of two MFC 
cascades and was identical as previously described [20]. 
The open circuit cascade consisted of six individual MFCs 
and the closed circuit cascade consisted of nine MFCs. The 
external load connected to the MFCs under the closed cir-
cuit conditions was 250 Ω, and this had been determined 
from previous polarisation experiments as being close to 
the optimum for maximum power transfer. Human urine was 
supplied to each cascade at a constant flow rate of 400 mL/
day, resulting in hydraulic retention time of 0.3 h per each 
individual MFC.
For Trial 2, MFCs were assembled using terracotta 
ceramic cylinders sealed at one end (Orwell Aquatics, 
UK) with the following dimensions: length 10 cm, outside 
diameter 2.9 cm, inside diameter 2.1 cm, and wall thick-
ness 4 mm. The anode electrode was made of carbon veil 
(carbon loading 30 mg/cm2) with a macro-surface area of 
300 cm2, which was folded and wrapped around the terra-
cotta tube with the use of nickel chromium (Ni–Cr) wire for 
current collection. The cathode was made of activated car-
bon [30% wet proofed with polytetrafluoroethylene (PTFE)] 
as previously described [7]. The 30 cm2 activated carbon-
coated cathode was inserted into the cylinder, held against 
the ceramic wall by inserting a rubber sponge and connected 
via stainless steel crocodile clip. The MFC was placed in a 
plastic container (~ 60 mL working volume) where the outer 
anode surface was fully immersed into the anolyte (urine). 
The multi-channel data logger 34972a (Farnell, UK) and the 
electrical load were connected to the Ni–Cr wire, which was 
wrapped around the electrode to collect the electrons from 
its surface. The setup included two individual MFC cas-
cades, consisting of nine MFCs each operated under closed 
circuit, with an external resistance of 100 Ω (obtained from 
polarisation experiment - see Fig. S2) applied (1–9) and 
another nine used as controls (1A–9A), which were operated 
under open circuit conditions, with no external resistance 
applied (no power generation). The MFCs within each cas-
cade were connected as shown in Fig. 1, but were separated 
by physical air gaps which allowed inter-unit isolation, to 
avoid conductive bridging.
The MFC anodes had already been established over a 
120-day period, as part of a previous experiment, which was 
originally inoculated with activated sewage sludge (Wes-
sex Water Scientific Laboratory, Saltford, UK). The influent 
Fig. 1  Experimental setup showing the two cascades of nine MFCs 
for Trials 2 and 3; MFC 1–9 closed circuit (with 100Ω of external 
resistance applied), MFC 1A–9A open circuit (without any external 
resistance). Trial 1 was identical but with six MFCs in the open cir-
cuit cascade. A dark cabinet was used for real-time bioluminescence 
measurements using photon detectors. Inset: terracotta MFCs. MFC 
numbers 1, 3, 6, 9 represent sampling points for bench top luminom-
eter readings and viable counts
 Journal of Industrial Microbiology & Biotechnology
1 3
consisted of neat human urine donated by adult volunteers 
with pH ranging from 6.45 to 7.1. The MFC cascades were 
fed with collected urine at a flow rate of 400 mL/day, which 
resulted in a hydraulic retention time of approximately 3.5 h. 
External load applied to the “closed circuit” MFC cascade 
was 100 Ω, determined from polarisation experiments, car-
ried out previously on identical MFCs.
Data capture and power output
The potential of MFCs was recorded in volts (V) against time 
by a multi-channel Agilent data logging device. Recorded 
data were processed and analysed using the GraphPad Prism 
version 5.01 software package (GraphPad, San Diego, USA).
The current (I) in amperes (A) was calculated using 
Ohm’s law, I = V/R, where V is the measured voltage in volts 
(V) and R is the known value of the external load resistor in 
ohms. Power (P) in watts (W) was calculated by multiplying 
voltage with current, P = I × V. Power density was calculated 
in terms of the electrode surface area, PDensity = P/v, where 
v is the volume of the anodic chamber (mL) as previously 
described [14]. A Hanna 8424 pH meter (Hanna, UK) was 
used for taking the pH measurements.
Pathogen inactivation trials
The pathogens used in both trials were obtained from the 
collection of the University of the West of England. All 
strains carried the pBBR1MCS-2 plasmid derivative con-
taining the luxCDABE operon of Photorhabdus lumine-
scens, which allowed in situ, real-time monitoring of the 
presence of pathogens and rate of metabolism. To maintain 
the plasmids within pathogen cells, urine was supplied with 
gentamicin (10 mg/L) (S. typhimurium and P. aeruginosa) 
and erythromycin (S. aureus). The urine–pathogen mix was 
made up and pumped into the cascade at the start of the 
experiment. A piece of anode material (2 cm × 2 cm) was 
attached to the anode at the start of the experiment, to evalu-
ate the attachment of the test organisms to the anode mate-
rials and their tendency of forming biofilms on the anode. 
At the end of the test experiment (24 h later), this piece 
of anode material was carefully removed using forceps and 
placed in 1 mL PBS buffer (pH 7). This was then vortexed 
briefly, serially diluted and plated on selective media.
To investigate the survival of pathogenic species in neat 
urine, 1 mL of urine was collected from the inlet tank and 
analysed for viable counts at the end of the experiment. 
Viable counts (colony-forming units/mL) from T0 (before 
introduction into the MFCs), Tx (urine–pathogen mix not 
introduced into the cascades, but set aside till the end of the 
experimental test) and from sampling points 1, 3, 6, 9 along 
the MFC cascades were performed by plating serially diluted 
replicates of the collected samples on selective nutrient agar 
and incubated at 37 °C for 16–24 h. Log-fold reduction of 
colony-forming units and bioluminescence were calculated 
using the following formula:
where A is the number of viable microorganisms or bio-
luminescence intensity of the urine–pathogen mix before 
introduction into the cascades and B is the number of viable 
microorganisms or bioluminescence intensity at various 
sampling points (effluents of MFC 1, 3, 6, 9), as previously 
described [12]. Bioluminescence measurement of the col-
lected 1 mL samples was conducted using a single-tube 
FB12 Luminometer (Berthold Detection Systems, Ger-
many) in relative light units (RLU). The standard devia-
tion (SD) was calculated using the log reduction values 
obtained from the replicated analysis. A two-way analysis 
of variance (ANOVA), with 95% confidence interval was 
conducted using GraphPad Prism Version 5.01 to test differ-
ences between the closed circuit and open circuit cascades.
In all cases, the model pathogenic strains were added to 
the MFCs with established electroactive biofilm generating 
stable electricity.
Trial 1
In the first trial, S. typhimurium strain was introduced into 
the small-scale, MFCs in the same manner as described 
previously in detail for S. enteritidis [12]. In brief, two indi-
vidual MFC cascades: open circuit and closed circuit cas-
cade were used in parallel to treat human urine, into which 
S. typhimurium was introduced (at an initial density of  105 
CFU/mL). Overall, the study and experimental setup in Trial 
1 was constructed in a similar manner to Trial 2 (as shown 
in Fig. 4), where the same S. typhimurium strain was also 
tested. The aim of using two different experimental setups 
was to compare the inactivation efficacy from two different 
MFC sizes.
Trial 2
In Trial 2, two identical Hamamatsu photon-detecting cam-
eras (Hamamatsu Photonics, K.K., Japan) were purchased 
and calibrated to the same settings. Both photon detectors 
were inserted after MFC #6 of the open and closed circuit 
MFC cascades. In Trial 2, Salmonella typhimurium and P. 
aeruginosa were grown in nutrient broth (100 mL each) 
until they reached the density of  1013 CFU/mL, harvested 
by centrifugation, re-suspended in 1 L of influent urine (with 
gentamycin 10 mg/L) and pumped through the cascades at 
17 mL/h. The urine/pathogen mix (density of  1012 CFU/
mL) was stirred periodically to prevent sedimentation of 
pathogens.
LR = log(A∕B),
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The photon sensors for Trials 2 and 3 (see Fig. 4) were 
placed after MFCs #6 in both closed and open circuit cas-
cades based on observations from preliminary tests which 
indicated that substantial pathogen decline was recorded 
after MFC #6 (Fig. S1). The use of two photon cameras 
made it possible to measure pathogen presence (biolumi-
nescence) at two different but equivalent locations simul-
taneously. At the end of the trial, samples were collected 
from MFCs #1, 3, 6, 9 (outflows) for offline luminescence 
and viable counts analyses. The real-time and offline lumi-
nometer measurement was carried out on two pathogenic 
bacteria (S. typhimurium and P. aeruginosa) introduced into 
the cascades in Trial 2.
Trial 3
Trial 3 was conducted in a similar manner to Trial 2. How-
ever, in this case the bioluminescent pathogen S. aureus 
was used as a model strain, with the difference that it was 
initially grown in 150 mL nutrient broth until a density of 
 1010 CFU/mL, centrifuged (11,000×g at 4 °C for 10 m) and 
re-suspended into 1 L of urine containing erythromycin 
(10 mg/L) giving a final concentration of  109. The cascade 
position for the two photon sensors was the same as in Trial 
2. At the end of the trial, samples were collected from MFCs 
#1, 3, 6, 9 (outflows) for offline luminescence and viable 
counts and analysed in triplicate.
The present MFC configuration, using small terracotta 
ceramic cylinders (Fig. 1) was recently demonstrated to be 
an efficient ceramic material for power generation. For this 
study, we evaluated the fate of different pathogens within 
the anodic chamber of terracotta ceramic material covering 
a wider range of species (Gram-positive and Gram-negative, 
as well facultative anaerobic bacteria).
Results and discussion
MFC performance and power generation
The performance in terms of absolute power recorded during 
Trial 1 was significantly lower than for the two other trials 
carried out using the larger MFCs. The average open circuit 
voltage observed for the OC cascade was of 401 ± 136 mV 
(Fig. 2a), whilst the average power at the end of the trial 
was 59 ± 22 µW (Fig. 2b). This was at least one order of 
magnitude lower than the levels of power produced in Trial 
2 and Trial 3. This difference may have been due to the 
size difference amongst several other factors; however, it is 
important to note that the power density as well as inactiva-
tion efficacy was higher for the smaller MFCs of this Trial 
1 (see further below).
The MFC performance observed during Trial 2 and Trial 
3 resulted in different levels of power output from other-
wise identical MFCs within the cascades. As the MFCs were 
only connected hydraulically, each MFC performed as an 
independent, electrically isolated unit, and was not affected 
by the performance of other MFCs via fluidic electrical 
conductance. Furthermore, the results of power generation 
suggest that the performance of the MFC units was largely 
independent of their position in the cascade. Power output in 
the closed circuit cascade of the trials 2 and 3 remained sta-
ble, with some of the MFCs generating nearly or over 1 mW, 
whilst other MFCs were producing power below 0.5 mW. 
This disparity might have resulted from the manual prepa-
ration of these MFCs, the contact between the electrodes 
(esp. the cathode) and the ceramic membrane as well as the 
differential colonisation of the anode electrode by different 
electroactive bacteria. Nevertheless, the stability observed in 
power output from the individual MFCs suggests that meta-
bolic steady states had been achieved, since this parameter 
is directly proportional to power generation. The average 
voltage output of the open circuit cascade was 630 ± 079 mV 
(Fig. 3a), while the average power output of the closed 
circuit MFC cascade from Trial 2 reached 763 ± 191 µW 
(Fig. 3b). For Trial 3, the average voltage output of the open 
circuit cascade was 703 ± 078 mV (Fig. 4a), while the aver-
age power output of the closed circuit MFC cascade reached 
718 ± 123 µW (Fig. 4b). 
Pathogen inactivation analysis
Trial 1
The pathogenic S. typhimurium introduced into the 
small-scale MFCs was efficiently removed despite the 
relatively low-power output. The average log reduction of 
CFU observed for the closed circuit cascade was equal to 
5.22 ± 0.26 for MFC9 and 3.09 ± 0.29 for MFC6 (over 18 h 
of operation) and outperformed the open circuit cascade 
composed of six MFCs with LR equal to 1.57 ± 0.06, which 
showed that the CFU–LR of the closed circuit was signifi-
cantly higher than that of the open circuit cascade when 
similar MFCs were compared (P < 0.05). Similarly, the MFC 
environment had an inhibitory effect on the metabolic activ-
ity of bioluminescent S. typhimurium revealing 4.21 ± 0.01 
RLU–LR values (MFC3) and 3.98 ± 0.02 (MFC6) against 
3.13 ± 0.02 observed in open circuit control (Fig. 2c, d). The 
reduction in pathogen numbers corresponds to an increase in 
pH from 6.97 in the influent to 9.61 within the reactors. Sim-
ilarly, there was a significant reduction in oxidation–reduc-
tion potential from − 65 in the influent to − 450 mV in 
Trial 1. These changes have probably resulted in a hostile 
environment for the alien pathogen, which in turn resulted 
in the observed reduction.
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The results indicated that small-scale MFCs were able 
to induce disinfection and efficiently deactivate pathogenic 
S. typhimurium cells. As with the absolute values in power 
output, the non-normalised LR–CFU values were also found 
to be lower in Trial 1, when compared to the results obtained 
in Trial 2 and Trial 3, where MFCs produced at least one 
order of magnitude higher than the previous power output 
(see Table 1).
Trial 2
To evaluate the viability of the pathogenic bacteria intro-
duced into the MFC cascade, offline luminometer analysis 
was carried out to measure their bioluminescence at differ-
ent points in the cascade system. The results showed sig-
nificantly higher log-fold reduction in bioluminescence of 
the samples taken from the closed circuit (P < 0.05), power-
generating MFC cascade than from the open circuit cascade. 
Specifically, there was a 3.8 ± 0.06 log-fold reduction of 
bioluminescence for the closed circuit cascade compared to 
2.01 ± 0.01 log reduction recorded for the open circuit cas-
cade (Fig. 3e). These results indicate that the characteristics 
of the power-generating MFC cascade were more inhibitory 
to the exogenous pathogenic organisms than the open circuit 
cascade resulting in greater reduction or suppression of the 
metabolic activities of the pathogens.
Our previous research has shown a direct correlation 
between bioluminescence from pathogenic species (whether 
in real time or offline), and viability/metabolic rate [8, 12]. 
Therefore, these results suggest that the power generation 
process was able to bring about significant reduction in the 
viability and metabolic rate of the target pathogens.
To further test the findings from the luminometer analy-
sis, effluent samples collected at different sampling points 
within the MFC cascades were inoculated onto selective 
agar media for viable counts and analysed in terms of col-
ony-forming units (CFUs). The results showed significantly 
higher log-fold reduction (LR) of CFUs of the samples taken 
from the closed circuit cascade than from the open circuit 
cascade (P < 0.05). For the power-generating closed circuit 
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Fig. 2  Results of Trial 1, where low-power, small-scale MFCs were used to test the fate of S. typhimurium strain: a Potential of the open circuit 
cascade. b Power output of closed circuit cascade. c Results of the log-fold reduction in bioluminescence and d colony-forming units (CFU)
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MFC cascade, CFU–LR of 7.79 ± 0.01 and 6.91 ± 0.04 were 
observed for P. aeruginosa and S. typhimurium, respectively, 
whilst LR of 3.25 ± 0.05 and 2.04 ± 0.13 were recorded in 
the open circuit cascade, respectively, (Fig. 3c, d), resulting 
in a difference of almost fivefold in logarithmic terms in both 
cases (Table 1). Two-way analysis of variance (ANOVA) 
at 95% confidence interval showed the observed difference 
between the closed and open circuit cascade is statistically 
Fig. 3  Results of Trial 2: electrical output levels from a open and b 
closed circuit cascades; c log-fold reduction of viable counts of Pseu-
domonas aeruginosa introduced to the closed and open circuit cas-
cades; d log-fold reduction of viable counts of Salmonella typhimu-
rium introduced to the closed and open circuit cascades; e log-fold 
reduction of luminometer measurements from the cascades inocu-
lated with pathogenic S. typhimurium and P. aeruginosa. f Real-time 
bioluminescence monitoring of both S. typhimurium and P. aerugi-
nosa treated in open and closed MFC cascades. Photon detector was 
located after MFC #6 in both cascades. LR data are represented by 
the average of three replicates ± standard deviation
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significant in both cases (P < 0.05).These results were 
in agreement with the data obtained from luminometer 
analysis.
Furthermore, the results from the real-time biolumines-
cence monitoring revealed strong signals from the open cir-
cuit cascade, while only a low signal was recorded for the 
closed circuit cascade (Fig. 3f), which corroborate with the 
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Fig. 4  Results of Trial 3. Power performance of a open and b closed 
circuit cascades; c log-fold reduction in viable counts (CFU/mL) of 
pathogenic S. aureus. d Log-fold reduction of bioluminescence along 
the cascades; e real-time bioluminescence monitoring of pathogenic 
S. aureus. Detector located after MFC #6 in both cascades. LR data 
are represented by the average of three replicates ± standard deviation
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previous luminometer and viable count results. This indi-
cates that many of the S. typhimurium and P. aeruginosa 
cells introduced into the open circuit cascade remained 
largely viable and active, while those in the close circuit cas-
cade were significantly inhibited and inactivated. The results 
from CFU and RLU (both online and offline) measurements 
indicated, that open circuit MFCs were inefficient in disin-
fection of both model organisms. In contrast, survival and 
activity of both pathogenic species in closed circuit MFCs 
were negligible.
Trial 3
In Trial 3, we assessed the fate of S. aureus in urine-fed 
MFCs cascades operated in a continuous flow. The results 
of offline bioluminescence measurements conducted on the 
effluents of selected MFCs revealed a significantly greater 
reduction (P < 0.05) in the bioluminescence across the 
closed circuit cascade than the open circuit cascade. The 
LR value reported for open circuit MFCs was 1.41 ± 0.2, 
while for the closed circuit cascade they reached 2.01 ± 0.1. 
This reduction is an indication of the ability of the power-
generating MFC to deactivate S. aureus cells in addition to 
Gram-negative pathogens when introduced into the cascades 
(Fig. 4d).
The result of bioluminescence assay was further corrobo-
rated by the viable counts measurements of the effluents, 
which also showed significantly greater reduction (in CFU) 
of the power-generating cascade (P < 0.05) when com-
pared to the open circuit cascade. Specifically, a CFU–LR 
of 4.01 ± 0.11 was recorded in the closed circuit cascade 
in contrast to only 0.70 ± 0.15 for the open circuit cascade 
(Fig. 4c). Since other parameters of the MFCs were kept 
the same, the results suggest that the power-generating 
process of the closed circuit MFCs was the major mecha-
nism facilitating the inactivation of the pathogenic S. aureus. 
The results of real-time bioluminescence monitoring of the 
viability of the pathogenic S. aureus also showed that after 
MFC #6, the detection of the pathogens was negligible in the 
closed circuit cascade, while strong bioluminescence signals 
were recorded for a period of 25 h in the open circuit cascade 
(Fig. 4e), an indication that while the S. aureus introduced 
into both cascades were alive and active in the open circuit 
cascade, they were inhibited and inactivated in the power-
generating closed circuit cascade. Table 1 provides a sum-
mary of both power and biological parameters obtained from 
the three trials.
The results observed in our current study (Trial 1, 2 and 
3) showed that the introduction of large quantities of real 
pathogens into the MFC cascade had no negative impact 
on power generation and by extension, on the electroactive 
biofilm community. They also highlight the unique abilities 
of closed circuit MFCs to not only generate usable power, 
but also achieve inactivation of pathogenic organisms intro-
duced into the cascades.
The three pathogenic organisms tested in the current 
study have been reported to form biofilms on different types 
of substrata [2, 5, 35], which could result in their retention 
within the anode of microbial fuel cells, thereby giving false 
reduction levels. In the current study, we found no indication 
of pathogen attachment to the anode either through the real-
time power output monitoring or through the analysis of the 
anodic biofilm. Only negligible quantities of pathogen cells 
were detected (Table 2).
Our previous study involving in situ pathogen inactivation 
in MFC cascades using S. enteritidis [8] has also shown that 
the pathogenic bacterial cells were not incorporated into the 
anodic biofilm of either closed or open circuit cascade. As 
Table 1  Summary of results obtained from the three individual trials of pathogen inactivation in urine-powered MFC cascade
Results show average of power output from MFCs in the cascade and average of triplicate LR analysis of influent and effluent from closed and 
open circuit cascades ± SD
RLU relative light unit, CFU colony-forming unit, LR log-fold reduction, S.t S. typhimurium, P.a P. aeruginosa, S.a S. aureus, OC open circuit, 
CC closed circuit, na not available
Trial MFC no. Closed circuit Open circuit Δ CFU–LR 
in CC and OC 
cascades
Power (µW) Luminom-
eter (RLU–
LR)
Viable counts (CFU–
LR)
Voltage (mV) Luminom-
eter (RLU–
LR)
Viable counts (CFU–
LR)
△ CC vs OC
#1 6 62 ± 22 3.98 ± 0.02 S.t: 3.09 ± 0.29 401 ± 136 3.13 ± 0.02 S.t: 1.57 ± 0.06 S.t: 2.02
9 59 ± 22 4.21 ± 0.01 S.t: 5.22 ± 0.26 na na na na
#2 6 634 ± 173 3.15 ± 0.02 S.t: 6.45 ± 0.06 612 ± 085 0.95 ± 0.02 S.t: 0.67± 0.09 S.t: 5.78
9 763 ± 191 3.80 ± 0.11 S.t: 6.91 ± 0.12 630 ± 079 2.02 ± 0.01 S.t: 2.04 ± 0.1 S.t: 4.87
9 763 ± 191 3.80 ± 0.11 P.a: 7.79 ± 0.11 630 ± 079 2.02 ± 0.01 P.a: 3.25 ± 01 P.a: 4.54
#3 9 718 ± 123 2.01 ± 0.11 S.a: 4.01 ± 0.10 703 ± 078 1.41 ± 0.02 S.a: 0.71 ± 0.1 S.a: 3.30
 Journal of Industrial Microbiology & Biotechnology
1 3
such, it is unlikely that the pathogens form a biofilm on the 
anode in the current study. However, evaluation of the patho-
gens viability in the inlet tank showed an increase in the num-
ber of pathogens, which suggests that keeping the pathogens 
in urine for up to 35 h, does not inhibit their growth during the 
duration of the experiment.
Previous research has shown that most of the microor-
ganisms within the anodic chamber whether planktonic or 
attached potentially contribute to the power-generating pro-
cess. These microorganisms might be electroactive or not, 
but contribute to the electricity generation as a result of their 
normal metabolic activities where they could provide suitable 
substrates to electrogenic bacterial community thereby aiding 
the power generation process [13]. Research has also shown 
that even some pathogenic organisms such as P. aeruginosa 
have been isolated from the electrogenic community within 
the anodic chamber of MFCs [29]. More so, introduction of 
P. aeruginosa for instance, from an aerobic to anaerobic envi-
ronment as is the case in the current study has the potential to 
enhance its electrogenic abilities as a result of improved anode 
biofilm formation by the organisms [38]. However, the addi-
tion of large numbers of pathogenic organisms into the anodic 
chamber in the current study did not lead to sudden increase in 
power output suggesting that their contribution to electricity 
generation, if any, is negligible. In all cases, the pathogenic 
organisms were introduced in already colonised anodes in 
well-established, power-generating MFCs. It is worth investi-
gating whether pathogens can contribute to the generation of 
power when they form part of the inoculum (i.e., inoculating 
a fresh cascade with contaminated urine/sludge) and this will 
form a part of our near term experimental work.
Mechanisms of disinfection in urine‑powered MFC 
cascades’ system
Several factors have been proposed to be responsible for the 
suppression of growth of exogenous organisms introduced 
into power-generating MFC cascades, and one of these is 
the high pH (> 9.5) recorded in urine-powered MFCs [12], 
which is inhibitory to bacterial growth. However, observa-
tion from the current study showed a negligible difference 
in pH recorded between closed and open circuit cascades. 
The pH of the open circuit cascade effluent (9.66) was in fact 
slightly higher than that of the closed circuit cascade (9.50), 
where significant pathogen inactivation was observed. 
Therefore, although high pH might have inhibited the growth 
of the pathogens, it was not shown to be the major factor 
in the pathogen inactivation processes in the current study.
One of the major differences between the open and closed 
circuit cascade was the sequential application of external 
resistance from 1500 Ω (at the start) to 100 Ω at the later 
stages of the MFC operation. External resistance affected 
not just the anode potential but also the development of the 
anodic biofilm and as such also affected current generation 
[17]. The development, diversity and distribution of anodic 
biofilm are affected by the external resistance, because of 
its influence on the degree of adaptation of the electroactive 
communities. Higher external resistance has been shown to 
result in better enrichment of the anode as well as more 
diverse anodic biofilm community than low external resist-
ance [17, 33]. Although these reports highlight the signifi-
cance of external resistance in the selection, adaptation and 
distribution of various anodic biofilm communities, they did 
not provide information on the impact of external resistance 
on exogenous bacteria, which were not part of the already 
developed biofilm.
Table 2  Distribution of remnant 
pathogens (P. aeruginosa and S. 
typhimurium) in urine-fed MFC 
cascades 24 h after pathogen 
test in attached piece of anode 
(4 cm2) and within the anolyte
Planktonic number in the liquid within the anode, Attached those found on the piece of anode material 
attached to the anode
Closed circuit Closed circuit Open circuit Open circuit
P. aureginosa (CFU/mL) S. typhimurium 
(CFU/mL)
P. aureginosa 
(CFU/mL)
S. typhimu-
rium (CFU/
mL)
Attached
T1 0 0 170 64
T3 86 68 366 88
T6 77 97 567 104
T9 100 66 840 98
Planktonic
T1 129 0 132 80
T3 213 5 210 275
T6 353 34 550 434
T9 344 33 734 373
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Intra- and interspecific interactions including compe-
titions and cooperation are important factors that could 
have influenced pathogen survivability within the anode 
of the MFCs. Research has shown that P. aeruginosa, 
for instance, is able to thrive in almost all environments 
because of its ability to interact with other bacteria within 
the environment. One of the unique qualities of P. aerugi-
nosa is the ability to release chemical signals with which 
to either cooperate with other bacteria to enhance its sur-
vival or to antagonise other bacteria in competition for the 
limited carbon source [19, 34]. As such, competition and 
other forms of inhibitory interactions between exogenous 
bacteria and the already established attached and plank-
tonic resident anodic communities for space and nutrients 
might also have resulted in the decline of the exogenous 
bacteria. However, these interactions would occur within 
both closed and open circuit cascades.
The electricity generation process, which is the biologi-
cally driven electrochemical reaction of the closed circuit 
cascades leads to reduced oxidation–reduction potential 
(ORP). Although this mechanism requires a dedicated 
and detailed study, we believe that ORP is the major con-
tributing factor for pathogen inactivation. Studies on the 
impact of changes in redox potential levels indicated that 
a decrease in redox potential under stressful conditions 
results in growth cessation in a number of common bacte-
ria including E. coli and B. subtilis [30, 31]. Furthermore, 
it has been shown that the electrode potential has a critical 
impact on the survival and development of bacteria within 
the MFCs [28]. The sharp decline in ORP in the current 
trials from − 50 in the influent to − 125 in the effluent in 
trials 2, 3 could have led to stressful conditions, which 
would inhibit the growth of the pathogens.
This is evidenced by the significantly higher pathogen 
log-fold reduction recorded in closed circuit cascades 
in Trial 2 and Trial 3, when compared to Trial 1, where 
the same S. typhimurium strain was used in our previous 
study, but in smaller scale, lower power MFCs. The abso-
lute power in the present work was tenfold higher in Trial 
2 and 3, than in Trial 1 or indeed in the previous study 
[12], which may account for the higher log-fold reduc-
tion levels (6.91 vs 5.22) and higher Δ log-fold reduction 
between closed and open circuit cascades (4.87 vs 3.65 for 
MFC9 and vs 2.02 for MFC6), respectively. However, by 
calculating the inactivation efficacy as “density”, i.e., nor-
malised to the MFC size (volumetric), then the outcome 
is different. The MFCs in Trial 1 had an anodic volume of 
11.4 mL, which (taking into account the 18.7 mL/h flow 
rate) resulted in a dilution rate of 1.64/h and a cascade 
HRT of 5.94 h. This means that the inactivation rate was 
0. 88 LR/h (MFC9) and 0.51 LR/h for MFC6. Using the 
same logic, the larger MFCs in Trials 2 and 3 achieved 
an inactivation rate of 0.22LR/h or 0.33 LR/h for MFC 6 
(for S. typhimurium) and 0.24LR/h and 0.12LR/h for P. 
aeruginosa and S. aureus, respectively. The inactivation 
rate for the smaller MFCs was therefore 4 × faster than 
that of the larger MFCs, and this may be attributed to the 
MFC design, volume, fluid dynamics as well as power 
performance.
The pathogenic organisms tested in the current study 
belong to different phyla of bacteria, including representa-
tives of Gram +ve and −ve. It is possible that similar fae-
cal–oral pathogens such as Campylobacter jejuni, patho-
genic E. coli, Plesiomonas shigelloides, Salmonella typhi, 
Shigella spp., Yersinia spp. and Vibrio cholera [25] could 
be potentially inactivated by the same conditions as well 
as the external resistance within a power-generating anodic 
chamber of MFC cascade. However, specific tests involv-
ing some more virulent pathogens endemic in the develop-
ing countries are underway to evaluate their fate within the 
anodic chamber of power-generating MFCs.
Implications of pathogen inactivation in MFCs 
cascade systems
Waterborne pathogens are introduced into the drinking-
water supplies mainly as a result of faecal contamination 
and improper sanitation and waste management. Some 
pathogens such as Salmonella spp., P. aeruginosa and S. 
aureus cause several kinds of infection in humans including 
diarrhoea, septicaemia, meningitis, endocarditis, osteomy-
elitis, pneumonia and typhoid fever which are still regular 
occurrences within communities in developing countries 
[10]. While a number of approaches have been utilised to 
enhance the ability of wastewater treatment plants to remove 
pathogenic organisms during water treatments, including the 
use of filters [31, 40], cases of large numbers of Salmonella 
spp. have been reported in wastewater effluents [20]. Pre-
vious studies have shown that the secondary and tertiary 
treatment could only produce 2–3 log-fold reduction in the 
number of pathogenic organisms including faecal coliforms 
and E. coli [9]. This is currently not sufficient to achieve the 
established discharge limits, especially for wastewater reuse 
in irrigation, whilst the use of chlorine and its derivatives, 
which appear effective, raise concerns about dangerous by-
products [40]. The results of the current study highlight the 
susceptibility of the three tested pathogens to the treatment 
within power-generating MFC cascades. The MFC technol-
ogy therefore offers a promising, low cost solution to the 
challenge of sanitation, and power generation, and could 
become a vital technology for the disinfection of liquid 
waste in the future, especially with continuous improvement 
of the power generation potentials of the technology.
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Conclusions
MFC technology is becoming a strong contender in the bio-
energy sector, as more of its applications are discovered. The 
current study highlights the potential of a power-generating, 
urine-fed MFC cascade effecting significant reduction in the 
numbers of exogenous organisms introduced into the sys-
tem. This is being achieved as a result of the unique condi-
tions within a power-generating anodic chamber of an MFC, 
which creates a stressful environment for the exogenous 
pathogenic organisms. MFC cascade systems therefore offer 
a unique solution that could prove useful for off-grid, low 
cost, sanitation and power generation in poor, remote areas 
around the world, places where the technology is thought to 
have ‘comparative advantage’ as a result of energy needs and 
suitable weather conditions.
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